Aug. 7 at 3:13 AM
$ABCL The upcoming readout is perhaps the biggest catalyst here, likely leading to substantial rise in SP. The research and trials leading to the readout, management commentary, and overall market sentiment indicate favorable results. While there’s still some risk, as with all investments in general and biotech in particular, the stakes are very high for shorts. I wish them best of luck, if they are still holding their short positions or continue to short this stock!
